{
  "text": "In patients with type 2 diabetes and chronic kidney disease, metformin use was associated with improved glycaemic control but increased risk of lactic acidosis in advanced renal impairment. This study evaluated long-term safety outcomes in a multicenter cohort.",
  "pmid": "38723421",
  "title": "Safety and effectiveness of metformin in patients with chronic kidney disease",
  "journal": "Journal of Clinical Endocrinology",
  "year": 2024,
  "authors": [
    "A. Smith",
    "B. Kumar",
    "C. Lee"
  ],
  "section": "Abstract",
  "chunk_index": 0,
  "source": "pubmed_api",
  "api_query": "metformin chronic kidney disease heart rate variability",
  "retrieved_at": "2026-02-04T11:21:34.135640Z",
  "entities": {
    "drugs": [],
    "conditions": [],
    "biomarkers": [],
    "symptoms": []
  },
  "relations": [],
  "kg_node_ids": {
    "drugs": [],
    "conditions": [],
    "biomarkers": [],
    "symptoms": []
  },
  "study_type": null,
  "confidence_level": null
}
